Sign in
4

Changes in Ownership

Korro Bio, Inc. Filed Acc 0001127602-23-020671

Chief Scientific Officer sold 2,698 shares at an average $0.38 ($1,025)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Loose Christopher R. Chief Scientific Officer 2023-07-11 Sale 10b5-1 −1,363 $0.37 $504 201,022 D: show line 1 in the form
Loose Christopher R. Chief Scientific Officer 2023-07-12 Sale 10b5-1 −1,335 $0.39 $521 199,687 D: show line 2 in the form
Open-market sales · 2,698 sh · avg $0.38 · $1,025
Loading xslF345X04/form4.xml…